Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs

Abstract

The nuclear hormone receptor, estrogen receptor α (ERα), and mitogen-activated protein kinases (MAPKs) play key roles in hormone-dependent cancers, and yet their interplay and the integration of their signaling inputs remain poorly understood. In these studies, we document that estrogen-occupied ERα activates and interacts with extracellular signal-regulated kinase 2 (ERK2), a downstream effector in the MAPK pathway, resulting in ERK2 and ERα colocalization at chromatin binding sites across the genome of breast cancer cells. This genomic colocalization, predominantly at conserved distal enhancer sites, requires the activation of both ERα and ERK2 and enables ERK2 modulation of estrogen-dependent gene expression and proliferation programs. The ERK2 substrate CREB1 was also activated and recruited to ERK2-bound chromatin following estrogen treatment and found to cooperate with ERα/ERK2 in regulating gene transcription and cell cycle progression. Our study reveals a novel paradigm with convergence of ERK2 and ERα at the chromatin level that positions this kinase to support nuclear receptor activities in crucial and direct ways, a mode of collaboration likely to underlie MAPK regulation of gene expression by other nuclear receptors as well.

View publisher note:

Articles of Significant Interest Selected from This Issue by the Editors

ACKNOWLEDGMENTS

We thank Karen Kieser and Rosa Ventrella for assistance in these studies.

This study was supported by grants from the Breast Cancer Research Foundation (to B.S.K.), the National Institutes of Health (R01 CA18119 and P01AG024387 to B.S.K.; T32ES007326 to Z.M.E.; R01DK074967, P01CA8011105, and DF/HCC Breast Cancer SPORE Grant P50C89393 to M.B.), and U.S. Department of Defense Breast Cancer Research Program Award (W81XWH-08-1-0214 to M.L.).

We declare no conflict of interest.